ClinicalTrials.gg
Sign In

Candidiasis clinical trials

The registry lists 132 studies for Candidiasis across more than 10 countries. 9 are recruiting or about to start. 58 of them are mainly about Candidiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-23. Counting its 4 narrower conditions too, such as Candidiasis, Vulvovaginal: 348 studies, 34 open.

Get an email when these change. Save the Candidiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
102
Terminated
10
Status unknown
9
Recruiting
6
Withdrawn
2
Not yet recruiting
2

Phase

Phase 3
26
Phase 2
18
Phase 1
14
Phase 4
14
Early Phase 1
1

Where

United States
55
France
16
Spain
11
Italy
9
Belgium
8
Canada
8

Who runs them

Pfizer (15) · Merck Sharp & Dohme LLC (9) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · National Cancer Institute (NCI) (6) · Astellas Pharma Inc (5) · Radboud University Medical Center (3) · Ferrer Internacional S.A. (2) · NovaDigm Therapeutics, Inc. (2)

What is being tested here

Drugs under test in Candidiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fluconazole1619
Posaconazole124
Probiotic101
Micafungin0512
Caspofungin027
Voriconazole026
Anidulafungin025
Rezafungin022
Nystatin002
Itraconazole002

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 6 Candidiasis studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 2 (33%) take children under 18. 3 (50%) are for women only and 0 (0%) for men only; 3 (50%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
101 (17%)0 (0%)
185 (83%)2 (33%)
305 (83%)2 (33%)
405 (83%)2 (33%)
505 (83%)2 (33%)
654 (67%)2 (33%)
754 (67%)2 (33%)
854 (67%)2 (33%)

Across all 132 studies, recruiting or not: 39% stop at 75 or younger and 34% at 65; 39% take children; 20% are for women only and 2% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Candidiasis studies take

Of 14 observational studies under Candidiasis, half reached primary completion within 27 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational27 mo11–33 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 132. Browse all 132 → or search them.